Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Scott Silvestry

Transplant Surgery Orlando, FL Medical Doctor

NPI 1922028547 CMS profile 269097

2415 N Orange Ave, Suite 700, Orlando, FL 32804

Open in the dashboard

General payments

$661,208

533 records reported · program years 2019–2025

Research payments

$1,227

Paid to them · 15 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$398,870 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Scott Silvestry of Orlando, FL is reported in the CMS Open Payments database as having received $661,208 across 533 general payments and $1,227 in research payments paid to them. Separately, studies naming them as principal investigator received $398,870 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Transplant Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $96,823 79
2024 General $165,254 98
2023 General $151,149 132
2022 General $91,252 75
2021 General $67,710 56
2020 General $29,288 26
2019 General $59,733 67
2019 Research $1,227 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Silvestry
  • Transplant Surgery median
  • Middle half of Transplant Surgery
  • National median

In program year 2025, general payments to Scott Silvestry were reported at $96,823. Among 555 Transplant Surgery profiles paid that year, the median was $421 and the middle half received between $116 and $2,169.

Show as a table
Year Scott Silvestry Transplant Surgery median Middle half National median
2019 $59,733 $203 $77–$1,249 $163
2020 $29,288 $149 $52–$1,366 $114
2021 $67,710 $168 $73–$2,008 $132
2022 $91,252 $213 $94–$1,464 $149
2023 $151,149 $262 $93–$1,458 $160
2024 $165,254 $354 $126–$2,252 $164
2025 $96,823 $421 $116–$2,169 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abiomed $499,021 263 payments
  2. Abbott Laboratories $102,446 149 payments
  3. Medtronic Vascular, Inc. $25,690 33 payments
  4. Medtronic, Inc. $12,446 20 payments
  5. Fresenius USA Marketing, Inc. $8,403 13 payments
  6. Maquet Cardiopulmonary GmbH $8,092 4 payments
  7. Davol Inc. $2,082 2 payments
  8. Maquet Cardiovascular U.S. Sales, L.L.C. $797 19 payments
  9. Edwards Lifesciences Corporation $672 7 payments
  10. CVRx, Inc. $480 4 payments
  11. Other $1,078 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $334,275 59 payments
  2. Consulting Fee $150,158 63 payments
  3. Travel and Lodging $113,133 167 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $38,700 17 payments
  5. Food and Beverage $18,675 219 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $5,700 3 payments
  7. Education $567 5 payments
Products named General payments · program years 2019–2025
  1. Impella $412,198 203 payments
  2. HeartMate 3 Left Ventricular Dev $44,677 25 payments
  3. THORATEC HEARTMATE 3 LVAS IMPLANT KIT Heart failure $30,266 79 payments
  4. HeartWare HVAD Ventricular Assist Devices $18,329 19 payments
  5. CARDIOMEMS $16,936 15 payments
  6. HLS SET $8,092 4 payments
  7. HeartWare HVAD Ventricular Assist Devices $6,834 6 payments
  8. CardioMEMS HF System $5,700 3 payments
  9. HeartMate 3 Left Ventricular Assist Device $2,508 10 payments
  10. THORATEC HEARTMATE 3 LVAS IMPLANT KIT Structural Heart $760 3 payments
  11. Other $5,278 71 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. TransMedics, Inc. $1,227 15 payments

Billing to Medicare

Part B · data year 2024 · 27 billing codes

Paid by Medicare

$34,004

Medicare's payments for the services billed

Medicare patients

42

Average age 75

Services billed

105

16 women, 26 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 75%
Atrial fibrillation 62%
Arthritis 55%
Diabetes 50%
Chronic kidney disease 48%
Depression 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

548 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Transplant Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record